Elevance Health Inc. Profile Avatar - Palmy Investing

Elevance Health Inc.

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people…
Medical - Healthcare Plans
US, Indianapolis [HQ]
Financials

Analysts

Earnings
Reported
Past Estimate Consensus
Future Estimate Consensus
EPS Revenue EBITDA EBIT SGA
FY EPS Revenue [mil.] Profit [mil.] EBITDA [mil.] EBIT [mil.] Expenses · SGA [mil.]
E E E E E E
All monetary values are presented in USD ($). E stands for Estimate.
2014 8.4900 7.910 71,023 70,296 2,489 2,423 4,749 5,507 61,070 3,115 9,952 11,140
2015 9.5800 10.177 73,874 78,381 2,569 2,201 5,219 5,410 62,125 3,473 11,748 11,253
2016 9.8000 10.865 79,156 83,862 2,560 2,386 5,538 5,972 66,621 3,716 12,534 12,052
2017 9.3600 11.996 84,863 88,932 2,469 3,500 5,467 4,954 72,305 3,941 12,557 11,499
2018 15.0100 15.725 90,039 91,699 3,842 3,510 4,854 6,505 77,389 4,063 12,649 13,073
2019 14.7500 19.426 92,105 103,499 3,750 4,728 6,195 7,739 178,389 4,586 14,020 13,187
2020 18.8100 22.423 104,213 120,365 4,807 4,482 7,118 8,025 200,449 5,334 13,364 17,206
2021 18.2300 25.942 121,867 137,850 4,572 5,674 7,392 9,339 238,927 6,109 17,450 14,911
2022 25.0400 29.023 138,639 156,295 6,158 6,081 9,227 10,146 111,830 8,162 15,914 16,859
2023 24.5600 33.068 156,595 170,382 5,894 5,987 9,444 11,161 125,874 8,898 17,686 18,545
2024 25.3800 33.579 171,340 175,550 5,987 7,971 1,741 10,727 115,782 9,168 36,450 7,425
2025 - 35.596 - 188,824 - 7,519 - 11,538 - 9,861 - 7,986
2026 - 41.322 - 203,577 - 2.F12X/td> - 2.F121/td> - 2.F121 - 2.F121
2027 - 50.368 - 230,854 - 1.F13X/td> - 1.F131/td> - 1.F131 - 1.F131
2028 - 57.820 - 319,438 - 0.F14X/td> - 0.F141/td> - 0.F141 - 0.F141
Institutional Sentiment
Morgan Stanley
1Y Ago:
Overweight
Prev. Grade
Overweight
Nov. 6, 2024
Overweight
JP Morgan Chase
1Y Ago:
Overweight
Prev. Grade
Overweight
Nov. 6, 2024
Overweight
Citigroup
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
Overall Consensus
Grading Consensus
Click to each, to see the grade
Price Target Consensus

-30.796% $123.97 · MISS

Nov. 6, 2024
Price Then
$417.77
Price Target
$526.52
Price Now
$402.55
End of ELV's Analysis
CIK: 1156039 CUSIP: 036752103 ISIN: US46138E2972 LEI: - UEI: -
Secondary Listings